Cosmetic cross-reference Noindex: medium evidence

10361-37-2

CAS 10361-37-2

10361-37-2 (CAS 10361-37-2) is a pharmaceutical compound with 0 bioactivity targets and 0 adverse event associations.

SOURCE NLM DailyMed
Label records
0
SOURCE EMBL-EBI ChEMBL
Bioactivity
0
SOURCE DrugCentral
Adverse signals
0
SOURCE IUPHAR/BPS
PubMed IDs
0
SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Compound Identity

Matched identifiers and naming fields for the pharmaceutical compound record.

Primary Name
10361-37-2
CAS Number
10361-37-2
UNII
0VK51DA1T2
InChIKey
WDIHJSXYQDMJHN-UHFFFAOYSA-L
ChEMBL ID
CHEMBL3184191
Molecule Type
Small molecule
Source Match
EMBL-EBI ChEMBL (INCHIKEY)
SOURCE Ingredients table / CosIng profile same-CAS cross-reference

Cross-Reference to Cosmetics

Same-CAS ingredient record found in the cosmetics vertical.

SOURCE Rendered pharma page rows FAQPage JSON-LD

Frequently Asked Questions

Short answers generated only from the same visible source-linked rows on this page.

What is 10361-37-2 used for in pharmaceutical contexts?

10361-37-2 (CAS 10361-37-2) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.

What are the known adverse events for 10361-37-2?

No adverse-event association or SIDER side-effect rows are rendered for 10361-37-2 in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.

Is 10361-37-2 also used in cosmetics?

Yes. The ingredients table has a same-CAS cosmetic profile for Barium Chloride with EU status "prohibited".

What clinical phase is 10361-37-2 in?

No phase 1-4 clinical development badge is rendered for 10361-37-2 because the matched compound identifier rows do not contain a max-phase value.